Results 101 to 110 of about 6,620 (194)

Síndromes hormonales paraneoplásicos

Anales del Sistema Sanitario de Navarra, 2008
En términos generales, podemos definir los síndromes paraneoplásicos como una combinación de efectos que ocurren lejos del lugar originario del tumor e independientemente de la repercusión local de sus metástasis. Los síndromes hormonales paraneoplásicos
L. Forga, E. Anda, J.P. Martínez de Esteban   +2 more
doaj  

The prognostic value of peripheral ischemic microvascular reserve in sepsis is not related to calcitonin gene-related peptide or substance P. [PDF]

Rev Bras Ter Intensiva, 2022
Miranda AC, Stefani FDC, Carraro Júnior H, Luy AM, Ferreira LEN, Morello LG, Menezes IAC.   +6 more
europepmc   +1 more source

Tratamiento de la neuropatía diabética periférica con calcitonina

, 2006
El manejo de la neuropatía diabética periférica dolorosa (NDPD) sigue siendo un reto debido a la pobre efectividad de los medicamentos corrientemente usados en su tratamiento. Muchos trabajos apoyan la hipótesis del daño vascular como primera alteración.
Obregon, Oswaldo, Brito, Sara, Rojas, Elizabeth, Contreras, Roberto, Vecchionacce, Hugo, Lares, Mary   +5 more
openaire   +1 more source

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications. [PDF]

Neurologia (Engl Ed), 2021
Caronna E, José Gallardo V, Alpuente A, Torres-Ferrus M, Sánchez-Mateo NM, Viguera-Romero J, López-Veloso AC, López-Bravo A, Gago-Veiga AB, Irimia Sieira P, Porta-Etessam J, Santos-Lasaosa S, Pozo-Rosich P, Spanish CGRP-COVID Study Group.   +13 more
europepmc   +1 more source

Biotin conjugates in targeted drug delivery: is it mediated by a biotin transporter, a yet to be identified receptor, or (an)other unknown mechanism(s)? [PDF]

J Enzyme Inhib Med Chem, 2023
Tripathi R, Guglani A, Ghorpade R, Wang B.   +3 more
europepmc   +1 more source

[Successful Management of Wearing-off effect with Eptinezumab: Lessons from a case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies]. [PDF]

Rev Neurol
Polanco Fernández M, Gangas Barranquero L, González-Quintanilla V, Madera Fernández J, Pascual J.   +4 more
europepmc   +1 more source

Calcitonina: experiencia en Chile

Medwave, 2002
openaire   +1 more source

Gepants: Key Features of A Potent Therapeutic Option and Considerations in The Latin American Context. [PDF]

Rev Neurol
Patiño DR, Zapata JC, Aguirre ALV.
europepmc   +1 more source

Consensus of the Brazilian Headache Society (SBCe) for the Prophylactic Treatment of Episodic Migraine: part I. [PDF]

Arq Neuropsiquiatr, 2022
Melhado EM, Santos PSF, Kaup AO, Costa ATNMD, Roesler CAP, Piovesan ÉJ, Sarmento EM, Theotonio GOM, Campos HC, Fortini I, Souza JA, Maciel Júnior JA, Segundo JBA, Carvalho JJF, Speziali JG, Calia LC, Barea LM, Queiroz LP, Souza MNP, Figueiredo MRCF, Costa MENM, Peres MFP, Jurno ME, Peixoto PM, Kowacs PA, Rocha-Filho PAS, Moreira Filho PF, Silva-Neto RP, Fragoso YD.   +28 more
europepmc   +1 more source

[Review of Osteoporotic Fractures: Occurrence, Prevention, and Consequences]. [PDF]

Rev Bras Ortop (Sao Paulo)
Elias N, Ribeiro JEG, Campinho LA, Reis C, Elias LAMS, Labronici PJ.   +5 more
europepmc   +1 more source